Association between RNAm-Based COVID-19 Vaccines and Permanency of Menstrual Cycle Alterations in Spanish Women: A Cross-Sectional Study
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Participants
2.2. Outcome Measures
2.3. Statistical Analysis
3. Results
4. Discussion
Limitations and Future Lines
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Lehmann, H.C.; Schoser, B.; Wunderlich, G.; Berlit, P.; Fink, G.R. Neuromuscular complications of SARS-CoV-2 infection-Part 2: Muscle disorders. Nervenarzt 2021, 92, 548–555. [Google Scholar] [CrossRef]
- Kaye, A.D.; Okeagu, C.N.; Pham, A.D.; Silva, R.A.; Hurley, J.J.; Arron, B.L.; Sarfraz, N.; Lee, H.N.; Ghali, G.E.; Gamble, J.W.; et al. Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives. Best Pract. Res. Clin. Anaesthesiol. 2021, 35, 293–306. [Google Scholar] [CrossRef] [PubMed]
- Guias, F. On efficacy and effectiveness of vaccines: A mathematical approach based on conditional probability with applications to the COVID-19 context. Spora J. Biomath. 2022, 8, 56–60. [Google Scholar]
- Andersson, P.A.; Tinghög, G.; Västfjäll, D. The effect of herd immunity thresholds on willingness to vaccinate. Humanit. Soc. Sci. Commun. 2022, 9, 243. [Google Scholar] [CrossRef] [PubMed]
- Asghar, N.; Mumtaz, H.; Syed, A.A.; Eqbal, F.; Maharjan, R.; Bamboria, A.; Shrehta, M. Safety, efficacy, and immunogenicity of COVID-19 vaccines; a systematic review. Immunol. Med. 2022, 1–13. [Google Scholar] [CrossRef]
- de Gregorio, C.; Colarusso, L.; Calcaterra, G.; Bassareo, P.P.; Ieni, A.; Mazzeo, A.T.; Ferrazzo, G.; Noto, A.; Koniari, I.; Mehta, J.L.; et al. Cerebral venous sinus thrombosis following COVID-19 vaccination: Analysis of 552 worldwide cases. Vaccines 2022, 10, 232. [Google Scholar] [CrossRef] [PubMed]
- Trougakos, I.P.; Stamatelopoulos, K.; Terpos, E.; Tsitsilonis, O.E.; Aivalioti, E.; Paraskevis, D.; Kastritis, E.; Pavlakis, G.N.; Dimopoulos, M.A. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications. J. Biomed. Sci. 2021, 28, 9. [Google Scholar] [CrossRef] [PubMed]
- Kirtipal, N.; Kumar, S.; Dubey, S.K.; Dwivedi, V.D.; Babu, K.G.; Malý, P.; Bharadwaj, S. Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage. Infect. Genet. Evol. 2022, 99, 105254. [Google Scholar] [CrossRef] [PubMed]
- Hikmet, F.; Méar, L.; Edvinsson, Å.; Micke, P.; Uhlén, M.; Lindskog, C. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 2020, 16, e9610. [Google Scholar] [CrossRef]
- Radzikowska, U.; Ding, M.; Tan, G.; Zhakparov, D.; Peng, Y.; Wawrzyniak, P.; Wang, M.; Li, S.; Morita, H.; Altunbulakli, C.; et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 2020, 75, 2829–2845. [Google Scholar] [CrossRef]
- Jing, Y.; Run-Qian, L.; Hao-Ran, W.; Hao-Ran, C.; Ya-Bin, L.; Yang, G.; Fei, C. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol. Hum. Reprod. 2020, 26, 367–373. [Google Scholar] [CrossRef]
- Richards, J.S. The ovarian cycle. Vitam. Horm. 2018, 107, 1–25. [Google Scholar]
- Lã, F.M.B.; Polo, N. Fundamental frequency variations across the menstrual cycle and the use of an oral Contraceptive pill. J. Speech Lang. Hear. Res. 2020, 63, 1033–1043. [Google Scholar] [CrossRef] [PubMed]
- Baker, F.C.; Lee, K.A. Menstrual cycle effects on sleep. Sleep Med. Clin. 2022, 17, 283–294. [Google Scholar] [CrossRef] [PubMed]
- Chmalenberger, K.M.; Tauseef, H.A.; Barone, J.C.; Owens, S.A.; Lieberman, L.; Jarczok, M.N.; Girdler, S.S.; Kiesner, J.; Ditzen, B.; Eisenlohr-Moul, T.A. How to study the menstrual cycle: Practical tools and recommendations. Psychoneuroendocrinology 2021, 123, 104895. [Google Scholar] [CrossRef]
- Rolla, E. Endometriosis: Advances and controversies in classification, pathogenesis, diagnosis, and treatment. F1000Research 2019, 8. ahead of print. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ferries-Rowe, E.; Corey, E.; Archer, J.S. Primary dysmenorrhea: Diagnosis and therapy. Obstet. Gynecol. 2020, 136, 1047–1058. [Google Scholar] [CrossRef]
- Appleton, S.M. Premenstrual syndrome: Evidence-based evaluation and treatment. Clin. Obstet. Gynecol. 2018, 61, 52–61. [Google Scholar] [CrossRef] [PubMed]
- Jewson, M.; Purohit, P.; Lumsden, M.A. Progesterone and abnormal uterine bleeding/menstrual disorders. Best Pract. Res. Clin. Obstet. Gynaecol. 2020, 69, 62–73. [Google Scholar] [CrossRef] [PubMed]
- Hallberg, L.; Hôgdahl, A.M.; Nilsson, L.; Rybo, G. Menstrual blood loss--a population study. Variation at different ages and attempts to define normality. Acta Obstet. Gynecol. Scand. 1966, 45, 320–351. [Google Scholar] [CrossRef] [PubMed]
- Male, V. Menstruation and covid-19 vaccination. BMJ 2022, 376, o142. [Google Scholar] [CrossRef]
- Baena-García, L.; Aparicio, V.A.; Molina-López, A.; Aranda, P.; Cámara-Roca, L.; Ocón-Hernández, O. Premenstrual and menstrual changes reported after COVID-19 vaccination: The EVA project. Womens Health 2022, 18, 17455057221112236. [Google Scholar] [CrossRef]
- Von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gøtzsche, P.C.; Vandenbroucke, J.P.; Strobe Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. J. Clin. Epidemiol. 2008, 61, 344–349. [Google Scholar] [CrossRef] [Green Version]
- World medical association Declaration of Helsinki ethical principles for medical research involving human subjects. JAMA 2013, 310, 2191–2194. [CrossRef] [Green Version]
- Hald, K.; Lieng, M. Assessment of periodic blood loss: Interindividual and intraindividual variations of pictorial blood loss assessment chart registrations. J. Minim. Invasive Gynecol. 2014, 21, 662–668. [Google Scholar] [CrossRef]
- Cohen, J. A power primer. Psychol. Bull. 1992, 112, 155–159. [Google Scholar] [CrossRef]
- Minakshi, R.; Rahman, S.; Ayaggari, A.; Dutta, D.; Shankar, A. Understanding the trauma of menstrual irregularity after COVID vaccination: A bird’s-eye view of female immunology. Front. Immunol. 2022, 13, 906091. [Google Scholar] [CrossRef]
- Cook, I.F. Sexual dimorphism of humoral immunity with human vaccines. Vaccine 2008, 26, 3551–3555. [Google Scholar] [CrossRef]
- Suzuki, S.; Hosono, A. No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study. Papillomavirus Res. 2018, 5, 96–103. [Google Scholar] [CrossRef]
- Gong, L.; Ji, H.H.; Tang, X.W.; Pan, L.Y.; Chen, X.; Jia, Y.T. Human papillomavirus vaccine-associated premature ovarian insufficiency and related adverse events: Data mining of Vaccine Adverse Event Reporting System. Sci. Rep. 2020, 10, 10762. [Google Scholar] [CrossRef] [PubMed]
- Laganà, A.S.; Veronesi, G.; Ghezzi, F.; Ferrario, M.M.; Cromi, A.; Bizzarri, M.; Garzon, S.; Cosentino, M. Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey. Open Med. 2022, 17, 475–484. [Google Scholar] [CrossRef] [PubMed]
- Han, S.M.; Shilen, A.; Heslin, K.M.; Ishimwe, P.; Allen, A.M.; Jacobs, E.T.; Farland, L.V. SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT study. Am. J. Obstet. Gynecol. 2022, 226, 270–273. [Google Scholar]
- Brady, E.; Nielsen, M.W.; Andersen, J.P.; Oertelt-Prigione, S. Lack of consideration of sex and gender in COVID-19 clinical studies. Nat. Commun. 2021, 12, 4015. [Google Scholar] [CrossRef] [PubMed]
- Edelman, A.; Boniface, E.R.; Benhar, E.; Han, L.; Matteson, K.A.; Favaro, C.; Pearson, J.T.; Darney, B.G. Association Between Menstrual Cycle Length and Coronavirus Disease 2019 (COVID-19) Vaccination: A U.S. Cohort. Obstet. Gynecol. 2022, 139, 481–489. [Google Scholar] [CrossRef] [PubMed]
- Trogstad, L. Increased Occurrence of Menstrual Disturbances in 18-to 30-Year-Old Women after COVID-19 Vaccination. Available SSRN 3998180. Available online: https://ssrn.com/abstract=3998180 (accessed on 25 September 2022).
- Nagma, S.; Kapoor, G.; Bharti, R.; Batra, A.; Batra, A.; Aggarwal, A.; Sablok, A. To evaluate the effect of perceived stress on menstrual function. J. Clin. Diagn. Res. 2015, 9, QC01–QC03. [Google Scholar] [CrossRef]
- Morrison, A.E.; Fleming, S.; Levy, M.J. A review of the pathophysiology of functional hypothalamic amenorrhoea in women subject to psychological stress, disordered eating, excessive exercise or a combination of these factors. Clin. Endocrinol. 2021, 95, 229–238. [Google Scholar] [CrossRef]
- de Arruda, G.T.; Driusso, P.; Rodrigues, J.C.; de Godoy, A.G.; Avila, M.A. Numerical rating scale for dysmenorrhea-related pain: A clinimetric study. Gynecol. Endocrinol. 2022, 38, 661–665. [Google Scholar] [CrossRef]
- Rodríguez Quejada, L.; Toro Wills, M.F.; Martínez-Ávila, M.C.; Patiño-Aldana, A.F. Menstrual cycle disturbances after COVID-19 vaccination. Womens Health 2022, 18, 17455057221109376. [Google Scholar] [CrossRef]
Time Since Last Dose (Months) | |||||
---|---|---|---|---|---|
Alterations | 0–1 | 2–3 | 3–4 | >5 | Total |
Yes | 65 | 125 | 75 | 219 | 484 |
No | 34 | 71 | 39 | 117 | 261 |
Total | 99 | 196 | 114 | 336 | 745 |
% | 66 | 64 | 66 | 65 | 65 |
Counts | % of Total | |
---|---|---|
↑ Duration of menstrual cycle | 221 | 24 |
↓ Duration of menstrual cycle | 113 | 12 |
↑ Bleeding amount | 155 | 17 |
↓ Bleeding amount | 85 | 9 |
↑ Pain | 223 | 24 |
↓ Pain | 27 | 3 |
Absence of menstrual cycle | 95 | 10 |
Total | 919 | 100 |
95% CI of M | Wilcoxon | ||||||||
---|---|---|---|---|---|---|---|---|---|
N | M | I | S | SD | Z | p | r | ||
Pain | Pre | 745 | 5.09 | 4.91 | 5.27 | 2.54 | −9.80 | <0.001 | −0.36 |
Post | 745 | 5.79 | 5.60 | 5.98 | 2.64 | ||||
Duration | Pre | 745 | 4.70 | 4.62 | 4.78 | 1.09 | −5.15 | <0.001 | −0.19 |
Post | 745 | 4.92 | 4.83 | 5.01 | 1.25 | ||||
Bleeding | Pre | 675 | 105.64 | 100.27 | 111.01 | 71.07 | −2.77 | 0.006 | −0.11 |
Post | 664 | 110.45 | 104.81 | 116.09 | 74.00 |
Pre | Post | Change (Post-Pre) | ||||
---|---|---|---|---|---|---|
Pain | Duration | Pain | Duration | Pain | Duration | |
Duration | 0.16 *** | 0.15 *** | 0.34 *** | |||
Bleeding | 0.19 *** | 0.32 *** | 0.18 *** | 0.32 *** | 0.32 *** | 0.47 *** |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mínguez-Esteban, I.; García-Ginés, P.; Romero-Morales, C.; Abuín-Porras, V.; Navia, J.A.; Alonso-Pérez, J.L.; de la Cueva-Reguera, M. Association between RNAm-Based COVID-19 Vaccines and Permanency of Menstrual Cycle Alterations in Spanish Women: A Cross-Sectional Study. Biology 2022, 11, 1579. https://doi.org/10.3390/biology11111579
Mínguez-Esteban I, García-Ginés P, Romero-Morales C, Abuín-Porras V, Navia JA, Alonso-Pérez JL, de la Cueva-Reguera M. Association between RNAm-Based COVID-19 Vaccines and Permanency of Menstrual Cycle Alterations in Spanish Women: A Cross-Sectional Study. Biology. 2022; 11(11):1579. https://doi.org/10.3390/biology11111579
Chicago/Turabian StyleMínguez-Esteban, Isabel, Pablo García-Ginés, Carlos Romero-Morales, Vanesa Abuín-Porras, Jose A. Navia, Jose Luis Alonso-Pérez, and Mónica de la Cueva-Reguera. 2022. "Association between RNAm-Based COVID-19 Vaccines and Permanency of Menstrual Cycle Alterations in Spanish Women: A Cross-Sectional Study" Biology 11, no. 11: 1579. https://doi.org/10.3390/biology11111579
APA StyleMínguez-Esteban, I., García-Ginés, P., Romero-Morales, C., Abuín-Porras, V., Navia, J. A., Alonso-Pérez, J. L., & de la Cueva-Reguera, M. (2022). Association between RNAm-Based COVID-19 Vaccines and Permanency of Menstrual Cycle Alterations in Spanish Women: A Cross-Sectional Study. Biology, 11(11), 1579. https://doi.org/10.3390/biology11111579